Wallman Richard F's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Nov 12, 2024
- Accession no.
- 0001127602-24-027032
- Filed
- Nov 12, 2024
- Trade date
- Nov 6-7, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.65M. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wallman Richard FCIK 0001198092 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Common Stock | GGiftDisposed | −4,540 | $0.00 | $0 | 19,007 | Direct | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −3,371 | $215.75 | −$727,293.25 | 15,636 | Direct | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −3,250 | $216.50 | −$703,625 | 12,386 | Direct | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −1,000 | $216.50 | −$216,500 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.